New Data on chronic spontaneous Urticaria (csU) - Significant Improvements in Quality of Life with Omalizumab (Xolair®)

被引：0
|
作者：
不详
机构：
来源：
ALLERGOLOGIE | 2015年 / 38卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：487 / 488
页数：2
相关论文
共 50 条
  • [1] Omalizumab (xolair) for chronic urticaria.
    Scofield, R. H.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S279 - S279
  • [2] Chronic spontaneous urticaria (CSU) associated with chronic inducible urticaria (CIndU): Efficacy of omalizumab
    Valle, S. O. R.
    Azizi, G. G.
    Dortas Junior, S. D.
    ALLERGY, 2019, 74 : 610 - 610
  • [3] Omalizumab for severe chronic spontaneous urticaria (CSU)-real life experience of 251 patients
    Vadasz, Z.
    Asher, I
    Tal, Y.
    Rotem, M.
    Shichter-Confino, V
    Greif, Y.
    Kessel, A.
    Agmon-Levin, N.
    Benor, S.
    Lachover-Roth, I
    Zeldin, Y.
    Stein, M.
    Toker, O.
    Mahlab-Guri, K.
    Bezalel-Rosenberg, S.
    Hassoun, J.
    Toubi, E.
    Sthoeger, Z.
    ALLERGY, 2017, 72 : 716 - 716
  • [4] Dupilumab Improves Urticaria Activity And Quality Of Life In Patients With Chronic Spontaneous Urticaria (CSU)
    Maurer, Marcus
    Casale, Thomas
    Saini, Sarbjot
    Ben-Shoshan, Moshe
    Radin, Allen
    Akinlade, Bolanle
    Fan, Chunpeng
    Bauer, Deborah
    Laws, Elizabeth
    Thomas, Ryan
    Mannent, Leda
    Stjepanovic, Aleksandra
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB98 - AB98
  • [5] REAL LIFE EXPERIENCE WITH OMALIZUMAB IN THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIA (CSU) IN A METROPOLITAN SPECIALIST CLINIC
    Katelaris, Constance H.
    Perram, Fiona A.
    Burton, Pamela K.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 29 - 29
  • [6] Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
    Yan, Che-Wen
    Cho, Yung-Tsu
    Chu, Chia-Yu
    DERMATOLOGICA SINICA, 2017, 35 (04) : 182 - 186
  • [7] Dupilumab Improves Urticaria Signs and Symptoms and Quality of Life in Patients With Chronic Spontaneous Urticaria (CSU)
    Maurer, Marcus
    Casale, Thomas B.
    Saini, Sarbjit S.
    Ben-Shoshan, Moshe
    Radin, Allen
    Bauer, Deborah
    Thomas, Ryan B.
    Mannent, Leda P.
    Stjepanovic, Aleksandra
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
  • [8] Improvements in quality of life and work productivity make omalizumab cost-effective for the treatment of chronic spontaneous urticaria
    Goncalo, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (03) : 562 - 563
  • [9] Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation
    Bras, Rita
    Costa, Celia
    Limao, Rita
    Caldeira, Leonor Esteves
    Paulino, Marisa
    Pedro, Elisa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (08): : 2392 - 2402
  • [10] The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data
    Salman, Andac
    Demir, Gizem
    Bekiroglu, Nural
    DERMATOLOGIC THERAPY, 2019, 32 (04)
12345